A Study to See How Well Bhringaraj Powder Works for Treating Acidity and Heartburns Problems

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF BHRINGARAJ CHURNA IN URDHVAGA AMLAPITTA W.S.R HYPERACIDITY - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086098

Enrollment

120

Registered

2025-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K90-K95- Other diseases of the digestive system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient age between 18 to 50 years. 2. Patient irrespective of gender & religion. 3. Patient having cardinal feature of Urdhvaga Amlapitta not more than 06 months. 4. Patients who are willing to give written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 18 years & above the age of 50 years. 2. Patients with any systemic/ chronic illness, any structural & functional deformities, pregnant & lactating women, gastric & peptic ulcer, Upper GI bleeding disorder, any specific findings in imaging studies. 3. Patient having cardinal feature of Urdhvaga Amlapitta more than 06 months.

Design outcomes

Primary

Measure	Time frame
Scoring pattern , adopted to assess the relief in each symptom as follows- Rogabala- Daha, Amlodgara, Chhardi, Adhmana, Gaurava. Agnibala- Avipaka, Aruchi. Timepoint: Assessment: Total 21 days (Follow-up in every 07 days). (Before & After treatment of trial drug Bhringaraja Churna shall be assessed.) BT (Before Treatment) AT 1 (After Treatment-1) With medicine. AT 2 (After Treatment-2) With medicine. AT 3 (After Treatment-3) Only followup without medicine.	—

Measure

Time frame

Scoring pattern , adopted to assess the relief in each symptom as follows- Rogabala- Daha, Amlodgara, Chhardi, Adhmana, Gaurava. Agnibala- Avipaka, Aruchi. Timepoint: Assessment: Total 21 days (Follow-up in every 07 days). (Before & After treatment of trial drug Bhringaraja Churna shall be assessed.) BT (Before Treatment) AT 1 (After Treatment-1) With medicine. AT 2 (After Treatment-2) With medicine. AT 3 (After Treatment-3) Only followup without medicine.

—

Secondary

Measure	Time frame
Scoring pattern , adopted to assess the relief in each symptom as follows- Rogabala- Daha, Amlodgara, Chhardi, Adhmana, Gaurava. Agnibala- Avipaka, Aruchi. Timepoint: Assessment: Total 21 days (Follow-up in every 07 days). (Before & After treatment of trial drug Bhringaraja Churna shall be assessed.) BT (Before Treatment) AT 1 (After Treatment-1) With medicine. AT 2 (After Treatment-2) With medicine. AT 3 (After Treatment-3) Only followup without medicine.	—

Measure

Time frame

—

Countries

India

Contacts

Public ContactProf Dr Vinayak Raghunath Anande

Desh Bhagat University,Amloh Road, Mandi Gobindgarh, Punjab

vanande@gmail.com8149639881

Outcome results